INOSINIC ACID Inhibitor

Inosinic acid is a purine nucleotide which has hypoxanthine as the base and one phosphate group esterified to the sugar moiety. Inosinic acid is a nucleotide present in muscle and other tissues. It is formed by the deamination of AMP and when hydrolysed produces inosine. Inosinic acid is the ribonucleotide of hypoxanthine and is the first compound formed during the synthesis of purine.Inosine 5'-monophosphate (IMP) is used as a substrate to study the distribution, specificity and kinetics of inosine-5'-monophosphate dehydrogenase (IMPDH).

1. Nakayama Y. Dynamic simulation of red blood cell metabolism and its application to the analysis of a pathological condition[J]. Theoretical Biology and Medical Modelling,2,1 (2005-05-09), 2005, 2 (1):18-18.
2. Snow R J, Mcconell G K, Shinewell J, et al. Creatine supplementation reduces muscle inosine monophosphate during endurance exercise in humans[J]. Med Sci Sports Exerc, 2005, 37 (12):2054-2061.
3. Castro-Gago M, Cid E, Trabazo S, et al. Cerebrospinal Fluid Purine Metabolites and Pyrimidine Bases After Brief Febrile Convulsions[J]. Epilepsia, 1995, 36 (5):471-474.

Small volumes of INOSINIC ACID, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS5751216 is an inhibitor targeting INOSINIC ACID.